Medtronic

Medtronic Accepts Defects in Insulin Pumps

Medtronic Accepts Defects in Insulin Pumps

Medtronic Inc has accepted that the defects in its security insulin pumps could help hackers control the device with a remote.

However, company officials have notified that the 200,000 diabetes patients who have been using the device should not worry as the risk of the cyber attack was near to the ground.

MDT And LLY Will Work in Collaboration for the Treatment of Parkinson

MDT And LLY Will Work in Collaboration for the Treatment of Parkinson

The researchers at the Medtronic Inc. (MDT) and Eli Lilly & Co. (LLY) said that a new treatment for the Parkinson’s disease will be developed for direct delivery of the medicine in to the brain. The companies announced on Tuesday that they will work on the treatment in collaboration, which may take decades.

Medtronic Resolves Issues with FDA

Medtronic Resolves Issues with FDA

On Wednesday Medtronic Inc. announced that the issues highlighted in the two warning letters from the Food and Drug Administration regarding their facilities in Mounds View and Juncos, Puerto Rico have been resolved. The resolution of these issues means that critical medical devices produced in these plants can now be made ready for introduction into the United States market.

Medtronic Cryoablation System Better than Anti-Arrhythmic Drugs

Medtronic Cryoablation System Better than Anti-Arrhythmic Drugs

Reuters shared that a new study has revealed that making use of a catherer to freeze heart tissue is more useful than other medications available for treatment of atrial fibrillation.

Medtronic pacemaker defect – physicians warned

Medtronic pacemaker

In a letter to physicians, Medtronic Inc. has warned that nearly 37,000 of its pacemakers, produced late 1990s onwards, could possibly have wiring defects due to which a malfunctioning of the medical equipment is quite possible.

Medtronic’s to commence first lot of 1,400 recruitments for new diabetes center

Medtronic’s to commence first lot of 1,400 recruitments for new diabetes center

In its endeavor to expand its growing diabetes business, the Minneapolis-based medical device maker Medtronic Inc. intends making 1,400 job-additions in the coming five-year period, at its new San Antonio, Texas-based customer support facility, scheduled to open late this summer.

Medtronic acquires CoreValve; Ventor Technologies

Minneapolis-headquartered Medtronic, Inc. has signed a definitive agreement to acquire CoreValve, Inc., developer of a transcatheter, transfemoral aortic valve replacement product.

Medtronic’s brain device receives FDA approval for severe anxiety disorder

Medtronic Inc’s implantable deep brain stimulator, Reclaim DBS Therapy, has received the FDA approval for facilitating the treatment process in severe cases of obsessive-compulsive disorder (OCD), in which drug and psychotherapy have been futile.

Latest News

5000 Leprosy Cases Identified in Western Pacific
Genome Sequence Helps in Determining Breeding Crocs
India-EU Tug of War Continues
The New Electric Cheque
Google to Modernize its Networking Sites
Brothers Turn Blind Because of Leber's Optic Neuropathy
Snyder Students Keen on Resolving the Risk of Disease Outbreak
Valentine's Gifts Can Be Dangerous for Your Pets
Need to Go for Regular Dental Checkup
Women Must Take Good Care of Their Heart
Internet is Lovers’ Cupid
Healthy Looking Skin Attracts Women towards Men
Syndicate content